MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number AFAPRO28 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226)
|
Event Date 11/16/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that during a cryo ablation procedure, after transseptal puncture and while trying to insert the exchange wire, it appeared that the catheters were on the [atrial] appendage and needed to be more careful.After a few attempts, the sheath was able to be exchanged and the procedure could begin.The patient's blood pressure decreased during the first application on the left superior pulmonary vein (lspv) and the physicians initially thought it was vagal response.The blood pressure increase to normal values after one minute.During the second application on the left inferior pulmonary vein (lipv), the blood pressure began to decrease again.An echocardiogram was performed and fluid that caused tamponade was observed.The procedure was aborted while the patient was under general anesthesia.A pericardiocentesis and left drainage was performed.The patient was moved to the intensive care unit (icu) and is stable but remains hospitalized.The next morning, some fluid was still present and additional drainage was required. no further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Product event summary: data files were returned and analyzed.One patient file was received and showed four applications were performed using balloon catheter afapro28 with lot 16062 on the date of the event, and no console system notices were generated.In conclusion, the reported clinical issue (tamponade and hypotension) cannot be assessed through data analysis.The balloon catheter was discarded and was not returned for analysis.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|